Browsing by Author "Roa, Juan"

Now showing items 1-4 of 4

    • Early gallbladder cancer: Is further treatment necessary? 
      Aretxabala, Xabier de; Roa, Iván; Hepp, Juan; Maluenda, Fernando; Mordojovich, Gerardo; Leon, Jorge; Roa, Juan (2009)
      Background and Objectives: The goal of this study was to evaluate a series of patients with early gallbladder cancer, focusing on the selection of treatment and the role of Rokitansky Aschoff sinus infiltration. Methods: ...
    • HPV genotyping from invasive cervical cancer in Chile 
      Roa, Juan; Garcia, Patricia; Gomez, Jorge; Fernández, Wanda; Gaete, Fancy; Espinoza, Arturo; Lepetic, Alejandro; Suarez, Eugenio (John Wiley and Sons Ltd, 2009)
      Objective: To determine the prevalence rates of the different HPV types in cervical cancer lesions in Chile to facilitate the development of prophylactic human papillomavirus (HPV) vaccines effective for that country. ...
    • The relationship between chemokines CCL2, CCL3, and CCL4 with the tumor microenvironment and tumor-associated ... 
      Fuente López, Marjorie de la; Landskron, Glauben; Parada, Daniela; Dubois Camacho, Karen; Simian, Daniela; Martínez, Maripaz; Romero, Diego; Roa, Juan; Chahuán, Isidora; Gutiérrez, Rocío; Lopez-K, Francisco; Alvarez, Karin; Kronberg, Udo; López, Sebastián; Sanguinetti, Antonella; Moreno, Natalia; Abedrapo Moreira, Mario Antonio; González, María Julieta; Quera, Rodrigo; Hermoso-R, Marcela (NLM (Medline), 2018)
      A complex network of chemokines can influence cancer progression with the recruitment and activation of hematopoietic cells, including macrophages to the supporting tumor stroma promoting carcinogenesis and metastasis. The ...
    • Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancer 
      Rojas-Sepúlveda, Daniel; Tittarelli, Andrés; Gleisner, María Alejandra; Ávalos, Ignacio; Pereda, Cristián; Gallegos, Iván; González, Fermín Eduardo; López, Mercedes Natalia; Butte, Jean Michel; Roa, Juan; Fluxá, Paula; Salazar Onfray, Flavio (Springer Science and Business Media Deutschland GmbH, 2018)
      © 2018, The Author(s). Immunotherapy based on checkpoint blockers has proven survival benefits in patients with melanoma and other malignancies. Nevertheless, a significant proportion of treated patients remains refractory, ...